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established stenoses.8,9 The detection of remediable
lesions by rigorous duplex surveillance programs has
gained wide acceptance.10-12 At present, the whole popu-
lation of infrainguinal vein grafts are surveyed because no
clear risk groups have been defined.
Interestingly, evidence from several experimental stud-
ies suggests that in a state of a low flow and a low shear
stress, the formation of myointimal hyperplasia is acceler-
ated.13-18 The purpose of this study was to evaluate the
value of graft volume flow measured during operation in
predicting the survival of infrainguinal vein grafts and,
moreover, whether it is predictive for the development of
de novo graft stenoses.
METHODS
Intraoperative flow measurements were performed in
276 infrainguinal vascular reconstructions with an autolo-
gous vein graft at the Division of Vascular Surgery,
Helsinki University Central Hospital, from July 1994
through June 1999, of which 257 infrainguinal vascular
reconstructions carried out in 247 patients are included in
this study. These represented 52% of all infrainguinal vein
graft reconstructions performed during this period. The
measurements were performed with a transit time flowme-
ter (CardioMed CM4006, Medistim A/S, Oslo, Norway).
The ultrasonic transit-time flowmeter is based on ultra-
sonic pulsed-beam technique and measures volume flow
within the conduit. A precalibrated probe is placed around
the vein graft of a size to fit the graft (from 3-5 mm). The
flow measurements have been found to be highly valid and
reproducible and are not dependent on vessel diameter,
Infrainguinal arterial bypass reconstructions are rou-
tinely performed on patients with severe lower limb vas-
cular disease. Autologous vein is the preferred conduit,
especially for bypasses extending below the knee.1
Unfortunately, the failure rate has remained high, and the
outcome of an occluded bypass after a take-back proce-
dure is bleak. In the immediate postoperative period,
reconstructions fail mainly because of technical or graft-
related defects, as well as because of compromised
runoff.2,3 Most midterm bypass occlusions are due to the
development of focal stenoses within the conduit or at the
anastomotic areas, with an incidence of 20% to 35% within
1 to 2 years after surgery.4,5
Myointimal hyperplasia, which is usually a self-limiting
process, is the universal response of a vein graft to inser-
tion into the arterial circulation. In focal areas, it can pro-
ceed to a significant stenosis, leading to graft failure.6,7
Because the pathophysiologic cause of myointimal hyper-
plasia is unknown, no effective clinical regimen to limit its
development is available.6 Thus, the treatment strategy
has been surgical or endovascular correction of already
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Objective: There are data to suggest that the development of myointimal hyperplasia is affected by long-term alterations
in blood flow. However, the clinical relevance of these findings has not been demonstrated.
Methods: In this retrospective clinical study, intraoperative volume flow measurement with transit time flowmeter was
performed in 257 infrainguinal vein grafts carried out in 241 patients. The patients were enrolled in an intensive duplex
scanning–based surveillance program. The relationship between the intraoperative graft flow and subsequent occlusion
or development of stenosis was evaluated and controlled for other pertinent risk factors.
Results: The median follow-up time was 13.6 months. A graft stenosis was found in 58 grafts. The mean graft flow for
event-free grafts was 98 mL/min, which was significantly higher compared with 78 mL/min for stenosed or 69
mL/min for occluded grafts. The patients were divided into four groups according to quartiles of the sample distrib-
ution of graft flow measurements. The respective 2-year primary and assisted primary patency rates in the lowest to the
highest graft flow groups were 39%, 49%, 47%, and 72% (P = .003) and 55%, 67%, 71%, and 84% (P = .01). Analogous
significant differences were observed for maximal flow capacity measurements. Female sex (P = .009) and low graft
flow in maximal flow capacity measurements (P = .003) were independent predictors of stenosis development in the
multiple regression model.
Conclusion: Intraoperative graft volume flow is a predictor of bypass occlusion after infrainguinal bypass. In addition,
this study verifies an association between the development of clinically evident graft stenoses and low graft flow. (J Vasc
Surg 2001;34:269-76.)
wall thickness, or hematocrit changes.19,20 The variability
in in vivo testing has been between 1.1% and 4.4%.19 The
graft flow was measured from the proximal part of 
the graft after the distal anastomosis was completed, and
the flow was opened and stabilized. The measurement was
repeated after injection of 40 mg of papaverine hydrochlo-
ride into the graft. This acts as a smooth muscle relaxant
that causes a transient vasodilation of the distal vascular
bed, and maximal flow capacity (MFC) is registered. This
was performed at the preference of the operating surgeon
and only in patients who were considered hemodynami-
cally stable and with a good diuresis. Overall, the MFC
was measured in 189 of 257 grafts. During operation the
reconstruction was evaluated with on-table angiography,
angioscopy, and invasive pressure measurements when
necessary and on the basis of the preference of the operat-
ing surgeon. If the intraoperative assessment prompted
corrective measures to technical issues within the bypass,
the flow measurements were repeated thereafter, and the
final values were taken into the analysis.
The patients were enrolled into a prospective graft sur-
veillance protocol at outpatient visits that included physi-
cal examination, ankle/brachial index measurements, and
color-flow duplex scanning at 4 to 6 weeks and 3, 6, 9, 12,
18, and 24 months after operation. The duplex examina-
tions were performed by means of a 7.5-MHz transducer
with either an ATL Ultramark 9 (Advanced Technology
Laboratories, Bothell, Wash) or an HP Image Point
(Hewlett Packard, Andover, Mass) ultrasound scanner.
The whole graft, including a few centimeters of inflow and
outflow arteries, was serially scanned, and specific struc-
tural abnormalities or exceptional flow patterns in color-
flow images were searched for. Peak systolic velocity (PSV)
measurements were performed routinely at multiple sites
along the course of the graft and especially at sites of
abnormal flow patterns.
The noninvasive criteria for a failing graft included a
decrease in ankle/brachial index greater than 0.15, PSV less
than 45 cm/s throughout the graft, or a focal disturbance
where the V2/V1 ratio exceeded 2.0 (V2 is the PSV at the
site of the stenosis, and V1 is the PSV at a nonstenosed
point within 2 cm on either side of the stenosed segment).
For these grafts confirmatory arteriography was usually per-
formed before graft revision. During the last 2 years of the
study period, the revision was performed on the basis of
duplex findings alone, on the condition that the stenosis
was clearly found and that it was limited to the graft.
The patients were identified through the hospital’s
vascular registry database, and the clinical records were
retrospectively reviewed. In 19 patients an adjuvant
arteriovenous fistula (AVF) was applied to the distal anas-
tomosis, and they were excluded from the analysis.
Data on patient demographics, risk factors, and proce-
dure specifications were entered into a computerized data-
base. The series was composed of 138 men and 119
women with a mean age of 71 years (range, 21-95 years).
The pertinent risk factors included a history of smoking
(30% of patients), diabetes mellitus (50%), hypertension
(42%), coronary artery disease (44%), history of cere-
brovascular accident (16%), chronic obstructive pul-
monary disease (10%), chronic renal insufficiency (14%),
and previous vascular reconstruction or amputation
(43%). The indication for revascularization was critical leg
ischemia in 85% of patients (Table I).
The bypass types were as follows: 73 (28%) femoral-
popliteal, 102 (40%) femoral-crural, 44 (17%) femoral-
pedal, and 38 (15%) popliteal-distal. In three recon-
structions a microvascular free flap muscle transfer was
anastomosed to the bypass in the same operation. In situ
vein was used as bypass conduit in 117 grafts, and reversed
or translocated nonreversed greater saphenous vein, as
well as spliced/alternative vein grafts, was used in 140
grafts.
The subsequent graft patency and duplex information
at the outpatient visits were recorded. Details about the
location and the length of the stenosis, V2/V1 ratio, and
time of occurrence were also recorded, as well as time and
type of revision operation. Only the first stenosis was
recorded, that is, if a recurrent stenosis developed at the
same bypass later during the follow-up, it was not added
to the total sum of stenoses. The end points of primary
patency were graft revision or occlusion.
Statistical analysis was performed with the aid of the
SPSS statistical software package (SPSS for Windows ver-
sion 9.0, SPSS, Chicago, Ill). Continuous variables are
presented as a mean, SD, and SEM, if not otherwise
stated. Because the distribution of flow values was skewed,
they are presented as a geometrically corrected mean. The
primary patency, assisted primary patency, and free-of-
stenosis rates were calculated by Kaplan-Meier survival
estimates (according to the guidelines of the Society for
Vascular Surgery/International Society for Cardiovascular
Surgery21), and comparison was performed with the log-
rank test. A multivariate analysis with a Cox proportional
hazard model was used to identify independent associa-
tions for significant group differences for free-of-stenosis
survival (Table II). Statistical significance was considered
for P values less than .05.
RESULTS
The median postoperative follow-up period was 13.6
months. Seventy-one grafts (28%) occluded during the
study period (median, 16 days; interquartile range, 3-108
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Table I. Indication for revascularization
Indication No. (%)
Intermittent claudication 28 (11)
Rest pain 52 (20)
Ischemic ulcer 104 (40)
Gangrene 63 (25)
Popliteal aneurysm 5 (2)
Acute-on-chronic ischemia 3 (1)
Graft infection 2 (1)
days). Graft stenosis developed in 58 (23%) grafts
(median, 186 days; interquartile range, 95-279 days). The
location of these stenoses were categorized as follows: 2
(3%) at the inflow artery; 4 (7%) at the proximal anasto-
mosis; 10 (17%) in the proximal graft; 29 (48%) in the dis-
tal graft; 11 (18%) at the distal anastomosis; and 2 (3%) at
the outflow artery. The temporal occurrence of the
stenoses is depicted in Fig 1. The mean V2/V1 ratio was
5.4 (range, 2-15). Of the detected stenoses 44 were
revised (Table III). In 14 grafts no revision procedure was
performed, of which 10 were mild stenoses that were
treated with intensified surveillance. Three grafts with
detected high-degree stenoses occluded before the sched-
uled angiogram, and on one occasion the leg was ampu-
tated with an open but stenosed graft resulting from
extensive foot gangrene.
For the whole series, the intraoperative graft flow and
the MFC were 86 mL/min (SD 74 mL/min; SEM 82-89
mL/min) and 136 mL/min (SD 130 mL/min; SEM
129-143 mL/min), respectively. The mean increase in the
flow after papaverine injection was 88%. When grouped on
the basis of survival, the grafts with event-free outcomes
had a higher graft flow (98 mL/min [SD 77; SEM 91-
104]) than grafts that either developed a stenosis (77
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mL/min [SD 43; SEM 72-83]) or occluded (68 mL/min
[SD 88; SEM 57-79]). MFC was also higher for event-
free grafts (158 mL/min [SD 144; SEM 143-171]) than
for stenosed or occluded grafts (115 mL/min [SD 76;
SEM 104-127]) and 106 mL/min (SD 138; SEM 93-
129), respectively). The respective mean flow and MFC
values for in situ grafts were 86 and 143 mL/min and for
non–in situ grafts were 85 and 130 mL/min.
A total of 207 grafts had their first scheduled duplex
scan performed. In this group 46 graft stenoses were
detected, of which 10 were identified in the first scan. The
development of de novo stenoses, defined as those that
occurred after 2 months after graft implantation and a
Table III. Type of revision procedure on 44 grafts
Procedure No. (%)
Vein patch angioplasty 16 (36)
Interposition graft 12 (27)
Distal extension jump graft 8 (18)
Percutaneous transluminal angioplasty 7 (16)
Endarterectomy 1 (2)
Table II. Univariate correlation of preoperative and intraoperative clinical parameters with the free-of-stenosis survival
Parameter No. of patients 2-year free-of-stenosis rate (%) Log rank P value
Sex Female 117 61
Male 138 77 .009
Diabetes mellitus Yes 128 62
No 127 72 .114
Smoking Yes 76 62
No 179 69 .615
Hypertension Yes 108 67
No 147 71 .353
Cardiac risk Yes 113 66
No 142 71 .97
Cerebrovascular disease Yes 42 72
No 213 69 .792
Chronic pulmonary disease Yes 27 55
No 226 71 .152
Renal insufficiency Yes 37 67
No 216 70 .951
Previous vascular operation Yes 110 64
No 145 74 .093
Preoperative ABI < 0.60 154 64
= 0.60 25 68 .9
Indication CLI 217 66
Other 38 75 .124
Grafting technique In situ 116 76
Other 139 64 .069
Bypass anatomy Femoropopliteal 72 72
Femorocrural 101 63
Femoropedal 44 70
Popliteal-distal 38 63 .258
Graft flow =130 mL/min 192 64
> 130 mL/min 63 82 .04
Maximal flow capacity = 200 mL/min 140 62
> 200 mL/min 47 89 .003
ABI, Ankle/brachial index.
normal first scheduled duplex scan, was recorded in 36
grafts. For these grafts, the graft flow and MFC were
lower than those for the event-free grafts (75 mL/min
[SD 36, SEM 70-81] and 123 mL/min [SD 81; SEM
109-138], respectively).
The overall primary and assisted primary patency rates
were 59% and 72% at 1 year and 52% and 70% at 2 years,
respectively. The sample for graft flow was divided into
quartiles (groups 1-4). The 25%, 50%, and 75% percentiles
were at 61 mL/min, 90 mL/min, and 130 ml/min,
respectively. After operation the ankle/brachial index
increased with a mean of 0.46, 0.45, 0.49, and 0.38 for
groups 1 through 4, respectively (NS). At 24 months the
primary patency rates were 39%, 49%, 47%, and 72%,
respectively (P = .0038), and the assisted primary patency
rates were 55%, 67%, 71%, and 84%, respectively (P =
.011) (Figs 2 and 3). The 24-month free-of-stenosis rates
for groups 1 through 4 were 59%, 66%, 68%, and 82%,
respectively (P = .040). The sample of MFC values was in
a similar manner divided into quartiles. The results of sur-
vival analysis were analogous to graft flow. The 2-year free-
of-stenosis survival rate for the lowest through highest
MFC quartile was 61%, 62%, 64%, and 90% (P = .027)
(Fig 4).
In addition to flow variables, only sex was a predictor
of graft stenosis (P = .009). Multiple regression analysis
indicated that sex and MFC were independent risk factors.
DISCUSSION
In an effort to reduce vein graft failure in infrainguinal
revascularization, intense investigation has been directed
to the detection and treatment of graft stenosis. Serial
duplex surveillance has been used as a means of detecting
these developing graft lesions, allowing timely repair
before graft failure. This strategy has gained widespread
acceptance, even though it is not known to what extent
the detected stenoses necessarily threaten graft patency.22
However, it is demonstrated that duplex scanning is an
accurate and reliable method to detect focal graft
lesions.23,24
An association between the development of vein graft
stenoses and several risk factors has been studied. Systemic
variables that might associate with graft stenosis are
lipoprotein (a), smoking and plasma fibrinogen,25 hyper-
homocystinemia,26,27 and antibodies to cardiolipin.28 The
importance of vein quality has been also studied. The
hypothesis of preimplantation morphologic changes in 
the saphenous vein as an etiologic factor of vein graft
stenosis is disputed.29-31 A small internal diameter of the
vein has been documented to increase the risk for vein
graft stenosis.32,33 In our study the vein diameter was not
measured during operation. The measurement of vein
graft diameter is a bit problematic, and comparison of
studies on vein size is difficult because the intraoperative
timing and the location where the measurements is taken
varies, and usually it is not stated. Ideally, the internal
diameter should be measured because the thickness of the
vein wall is variable. By contrast, we found that stenoses
were significantly more common in women, which is in
accordance with a recent finding in a European multicen-
ter study.34 This fact may relate to a smaller vein diameter
or to a higher prevalence of venous disease in women.35 In
the trial by Idu et al,32 where small graft diameter was
found to be a sole risk factor for graft stenosis, the impact
of sex was not controlled in their risk analysis model.
Because it has been suggested that preexisting intrin-
sic abnormalities in vein grafts form the basis of progres-
sive hyperplastic lesions, attempts to identify promoters
already at the time of operation for subsequent develop-
ment of graft stenosis have been made. Bandyk et al36
studied the fate of moderate duplex abnormalities that
were encountered during operation but were left
untreated. A revision was needed in 18 of 40 such grafts
(45%). The follow-up, however, was only 3 months, and
the study was not blinded. Wilson et al37 and Olojugba et
al38 have studied the predictive value of predischarge
duplex scanning for risk graft identification with conflict-
ing results. To sum up the information available, efforts to
allocate grafts into high- and low-risk categories in relation
to the stenosis development have not been successful, and
still no method of decreasing the number of grafts under-
going surveillance exists.
Since the advent of transit time flowmeter measure-
ments, it has been easy to measure graft volume flow accu-
rately and reliably during surgery.19,20 As a method for
intraoperative assessment of the technical adequacy of the
bypass, its role is dubious. When the in situ grafting tech-
nique is used, unligated side branch AVFs are easily
detected.39 Otherwise the potential technical errors of the
bypass cannot be assessed sufficiently with flow measure-
ment only.40 With current methods, the graft volume flow
can be accurately measured only during operation. It can
be derived from postoperative duplex scanning velocity
measurements, but they are shown to be unreliable and
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Fig 1. Fifty-eight graft stenoses were detected. Most of them
were located in body of graft.
poorly reproducible.41 The calculation of flow varies in
relation to the fourth power of the radius of the vessel.
This means that small inaccuracy in diameter measurement
alters the derived flow value dramatically.
As a predictor of outcome, it has previously been
demonstrated that low graft flow increases the risk of graft
thrombosis not only in the immediate postoperative
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period, but also later in the follow-up.42,43 Our data con-
firm these findings because the difference in the assisted
primary patency rate at 2 years between lowest and high-
est flow quartile was 36%, with an increasing tendency
during the first postoperative year.
The biomedical background with regard to how
hemodynamic alterations affect the development of myo-
Fig 2. Kaplan-Meier analysis of primary patency as function of intraoperative graft flow. At 2 years, pri-
mary patency rates were 39%, 49%, 47%, and 72% for groups 1 through 4 (P < .0038).
Fig 3. Kaplan-Meier analysis of assisted primary patency for flow quartiles also showed improved survival
with increasing intraoperative graft flow. Assisted primary patency rates at 2 years were 55%, 67%, 71%, and
84% for groups 1 through 4 (P < .011).
intimal hyperplasia is intriguing. It has increasingly been
recognized that the vascular endothelium is a living organ
in which the metabolism and synthetic activities of differ-
ent vasoactive factors are altered as a response to biome-
chanical forces generated by the blood flow.44 In normal
arteries the flow-induced remodeling results in changes in
arterial diameter that return wall shear stress toward nor-
mal in a negative feedback manner.45 Furthermore,
Fillinger et al46 demonstrated that the same phenomenon
takes place in vein grafts; in response to changes in shear
stress 1 year after operation, the small-diameter veins were
remodeled to a final diameter that was not significantly
different from larger veins. This remodeling might con-
tribute to the pathophysiological condition of neointimal
hyperplasia because it is shown that shear stress can regu-
late endothelial smooth muscle cell migration and prolif-
eration.47 It is probable that this is mediated by nitric
oxide, a potential vasodilator that causes vessel wall atro-
phy. In an experimental in vivo model, the endothelial
nitric oxide synthesis was induced in high-flow graft
intima.48
Furthermore, the synthesis of tissue-type plasminogen
activator is known to be triggered dependently by shear
force.49 It is plausible that the more efficient the initial fi-
brinolytic activity is, the less stabilized the fibrin form is on
the new conduit surface. The activity of the fibrinolytic
system is linked to cardiovascular tissue remodeling and
pathophysiologic study of myointimal hyperplasia.50 In
later stages of myointimal hyperplasia, the upregulation of
fibrinolytic and its regulatory enzymes is induced.51
Therefore, an appealing idea is to augment flow in the
graft with a distal AVF. Faulkner et al52 demonstrated in
the 1970s that the application of AVF decreases the
amount of subendothelial proliferation in vein grafts in
dogs. In clinical outcome studies the interest has concen-
trated on combining adjuvant AVF with a prosthetic
infrainguinal bypass, but the potential additional clinical
advantage of this method is still undetermined.53,54 The
clinical value of AVF as an adjunct to vein bypass grafting
has remained unexplored. We have gained some limited
experience combining adjuvant AVFs to vein bypass grafts.
This has not been, however, a common practice and has
been reserved as a last option in extreme cases, where a
successful outcome of the reconstruction has been judged
as unlikely. They were excluded from this analysis because
potentially these grafts with elevated flow rates would have
biased the results. On the other hand, their number was
too small to allow meaningful subanalysis.
It would be beneficial to find flow criteria for risk group
stratification for future surveillance programs. On the basis
of the data reported herein, it seems that high graft flow is
protective against the development of de novo graft steno-
sis because only four grafts in the highest quartile had
development of a stenosis after a normal duplex scanning
result within 6 weeks. It is a matter of discussion whether
this risk is acceptably low, so that discontinuation of sur-
veillance for grafts with high flow and normal early duplex
scanning results can be recommended. At this point, how-
ever, the merits of the data presented in this series should be
viewed as preliminary clinical verification that the myointi-
mal growth and regression in infrainguinal vein grafts are
regulated by blood flow. In our opinion a larger sample size
is needed for more reliable risk and best cutoff point calcu-
lation before clinical guidelines can be drawn.
In conclusion, this study confirms that intraoperative
graft flow is a predictor of bypass occlusion after infrain-
guinal bypasses after the immediate postoperative period.
Interestingly, it also indicates that the development of clin-
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Fig 4. Free-of-stenosis survival rates for lowest through highest MFC quartile were 61%, 62%, 64%, and
90% at 2 years (P = .027).
ically evident graft stenoses may be induced by low graft
flow. Further experience is needed with a greater number of
patients and longer follow-up, before it is evident whether
these findings have consequences in clinical practice.
We thank Hanna Oksanen, MSc, PhD, for her valu-
able consulting aid with the statistical analysis.
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